Related Experiment Video
Updated: Jul 17, 2026
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Androgen associated hepatocellular carcinoma with an aggressive course
D Gleeson1, M J Newbould, P Taylor
1Department of Gastroenterology, Royal Infirmary, Manchester.
Hepatocellular carcinomas from androgen treatment usually have a benign outcome. However, one patient experienced an aggressive, fatal cancer after 24 years of androgen therapy, challenging this notion.
Area of Science:
- Hepatology
- Oncology
- Endocrinology
Background:
- Androgen treatment is associated with hepatocellular carcinoma (HCC) development.
- Previously, these tumors were considered to have a benign clinical outcome.
Observation:
- A case study of a male patient undergoing androgen treatment for 24 years.
- Development of hepatocellular carcinoma after prolonged androgen exposure.
Findings:
- The patient's tumor initially showed partial regression upon androgen withdrawal.
- Subsequently, the tumor exhibited an aggressive and ultimately fatal clinical course, contradicting previous observations.
Implications:
- This case challenges the established understanding of the clinical behavior of androgen-associated HCC.
- Highlights the need for careful monitoring and consideration of aggressive treatment strategies in select cases.
- Suggests potential variability in tumor response and progression despite androgen treatment.
More Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
07:32Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
Published on: April 12, 2024